Home > Insider Trading > Filing (0001209191-20-006298)

Filing Details

Accession Number:: 0001209191-20-006298
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-02-04 16:15:33
Reporting Period:: 2020-01-31

Accepted Time:: 2020-02-04 16:15:33
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875320	Vertex Pharmaceuticals Inc / Ma	VRTX	Pharmaceutical Preparations (2834)	043039129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1197036	I Bruce Sachs	C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-01-31	20,000	$53.85	31,210	No	4	M	Direct
Common Stock	Disposition	2020-01-31	1,700	$224.02	29,510	No	4	S	Direct
Common Stock	Disposition	2020-01-31	1,858	$224.98	27,652	No	4	S	Direct
Common Stock	Disposition	2020-01-31	4,198	$226.32	23,454	No	4	S	Direct
Common Stock	Disposition	2020-01-31	5,644	$227.01	17,810	No	4	S	Direct
Common Stock	Disposition	2020-01-31	300	$227.66	17,510	No	4	S	Direct
Common Stock	Disposition	2020-01-31	600	$228.33	16,910	No	4	S	Direct
Common Stock	Disposition	2020-01-31	500	$229.90	16,410	No	4	S	Direct
Common Stock	Disposition	2020-01-31	1,200	$230.87	15,210	No	4	S	Direct
Common Stock	Disposition	2020-01-31	1,200	$232.04	14,010	No	4	S	Direct
Common Stock	Disposition	2020-01-31	1,800	$233.13	12,210	No	4	S	Direct
Common Stock	Disposition	2020-01-31	900	$234.15	11,310	No	4	S	Direct
Common Stock	Disposition	2020-01-31	100	$235.40	11,210	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2020-01-31	20,000	$0.00	20,000	$53.85

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2021-05-31	No	4	M	Direct

Footnotes

Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $224.02 (range $223.58 to $224.40).
Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $224.98 (range $224.66 to $225.21).
Open market sales reported on this line occurred at a weighted average price of $226.32 (range $225.62 to $226.60).
Open market sales reported on this line occurred at a weighted average price of $227.01 (range $226.70 to $227.59).
Open market sales reported on this line occurred at a weighted average price of $227.66 (range $227.62 to $227.70).
Open market sales reported on this line occurred at a weighted average price of $228.33 (range $227.97 to $228.78).
Open market sales reported on this line occurred at a weighted average price of $229.90 (range $229.16 to $230.12).
Open market sales reported on this line occurred at a weighted average price of $230.87 (range $230.32 to $231.23).
Open market sales reported on this line occurred at a weighted average price of $232.04 (range $231.45 to $232.42).
Open market sales reported on this line occurred at a weighted average price of $233.13 (range $232.69 to $233.49).
Open market sales reported on this line occurred at a weighted average price of $234.15 (range $233.77 to $234.66).
Fully vested.